Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-26 @ 12:26 AM
Study NCT ID:
NCT07273760
Status:
COMPLETED
Last Update Posted:
2025-12-10
First Post:
2025-11-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation
Sponsor:
AryoGen Pharmed Co.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-16
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-05
Completion Date Type:
ACTUAL
First Submit Date:
2025-11-25
First Submit QC Date:
None
Study First Post Date:
2025-12-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-09
Last Update Post Date:
2025-12-10
Last Update Post Date Type:
ESTIMATED